SAN CARLOS, Calif.--(BUSINESS WIRE)--Elegen, a leader in DNA manufacturing innovation, today announced a collaboration and licensing agreement with GSK (LSE/NYSE: GSK) to enable its use of Elegen’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback